Programme
The livestreamed sessions were recorded for on-demand viewing until 25 January 2026 (registered participants only).
Validating biomarkers for precision psychiatry
Turning scientific promise into clinical progress
A pivotal 1.5-day meeting hosted by ECNP, dedicated to advancing the clinical application of precision psychiatry.
As part of ECNP’s Roadmap initiative to redefine the diagnostic framework for mental disorders, this high-impact event will spotlight the urgent need to move from conceptual frameworks to real-world implementation. Building on previous meetings that explored scientific foundations and methodological approaches, this meeting shifts the focus to biomarker-driven strategies aimed at revolutionising psychiatric drug development and patient care.
Why attend?
Precision psychiatry offers a transformative approach to understanding and treating mental illness—rooted in objective, biologically informed markers rather than symptom-based categories. This meeting will bring together all key stakeholders:
- Regulatory authorities
- Clinicians and researchers
- Industry leaders
- Health technology assessors
- Payers and policymakers
- Patient advocacy groups
Together, we will explore how biomarkers can:
- Enable better patient stratification and dose selection
- Improve clinical trial design and outcomes
- Streamline regulatory and reimbursement pathways
- Inform personalised treatment strategies in real-world settings
Key themes include:
- Identifying the most urgent biomarker needs
- Validating tools for clinical use
- Replacing traditional diagnostic models with transdiagnostic, brain-based frameworks
Past meeting
Check the previous meeting below: